Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
1,022,530
-
Total 13F shares
-
172,925
-
Share change
-
+25,625
-
Total reported value
-
$356,768
-
Price per share
-
$2.07
-
Number of holders
-
10
-
Value change
-
+$28,998
-
Number of buys
-
6
-
Number of sells
-
3
Institutional Holders of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) as of Q4 2022
As of 31 Dec 2022,
Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
172,925 shares.
The largest 10 holders included
AdvisorShares Investments LLC, BlackRock Inc., VANGUARD GROUP INC, Tower Research Capital LLC (TRC), UBS Group AG, GROUP ONE TRADING, L.P., BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, MORGAN STANLEY, and CREDIT SUISSE AG/.
This page lists
10
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.